INHIBRX, INC.

• LA JOLLA, CA How do I update this listing?

Inhibrx is based out of La Jolla. Inhibrx, Inc. offers biologic therapeutics for people with life-threatening conditions. The Company focuses on developing a diverse pipeline of therapeutic candidates. Inhibrx serves customers worldwide.Whalewisdom has at least 4 13G filings The firm last filed a Form D notice of exempt offering of securities on 2020-04-16. The notice included securities offered of Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

inhibrx, inc.
11025 N. TORREY PINES ROAD, SUITE 200
LA JOLLA CA 92037
Business Phone: (858) 795-4220

SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Current 13D/G Holdings
Stock	Sector	Shares Held	Market Value	Rank	Source	Source Date
Inhibrx, Inc. (INBX)	HEALTH CARE	3,188,998	71,050,875.44	1	13G	2021-12-31

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold	Total Remaining
2020-04-16	D	BIOTECHNOLOGY	Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security	30,000,000	15,000,000	15,000,000
2019-05-31	D	BIOTECHNOLOGY	Equity,Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security	40,000,000	40,000,000	0
2018-05-11	D	BIOTECHNOLOGY	Equity	75,000,000	3,550,000	71,450,000
2018-05-10	D	BIOTECHNOLOGY	Equity	410,000,006	410,000,006	0

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
MARK LAPPE	subscription required	EXECUTIVE OFFICER DIRECTOR
BRENDAN ECKELMAN	subscription required	DIRECTOR
JON FAIZ KAYYEM	subscription required	DIRECTOR
MARGERY FISCHBEIN	subscription required	DIRECTOR
DOUG FORSYTH	subscription required	DIRECTOR
JUDITH LI	subscription required	DIRECTOR
KELLY DECK	subscription required	EXECUTIVE OFFICER